Symptoms
Next gen ECP leaders introduced
PSA introduced the new crop of leaders for the ECP Community of Specialty Interest to empower the next generation of pharmacists.
Systemic corticosteroids for dyspnoea
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer.
Dyspnoea affects almost 70% of advanced cancer patients at the...
PSA National President opening address at PSA24
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).
Visionary pharmacist named year’s best at PSA18
John Jackson FPS has been named PSA Pharmacist of the Year for his decades-long commitment to developing new practice and funding models, and for...
From the President: For 25 years, accreditation has paved the way
For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.
Case study: Uncovering Josef’s asthma flare-ups
If your patient is experiencing an increase in the frequency or severity of asthma symptoms or an increased reliance on their asthma inhaler, allergies could be the hidden cause.
